The High Potent Medicines Conference
Published on 01st February
The manufacturing of high potent medicines has provided many challenges in terms of safe production, containment and handling due to their toxic nature. But due to changing strategies and supportive regulatory framework to protect patent infringement, pharmaceutical companies are now focusing on commercialization and development of the high potent medicines to build their pipeline of products.
While most of the highly potent drugs under development are for oncology treatments, there are also new advances in high potent compounds manufacturing particularly antibody-drug conjugates (ADC’s) which are the fastest growing segment as they deliver the cytotoxic drugs to the targeted cells.
MarketsandMarkets is proud to announce The High Potent Medicines Conference to be held on 6th-7th June 2017 in Berlin, Germany. The conference aims to focus on sharing the current market trends, technological advancements and future challenges in the high potent medicines industry where the leading experts from the industry will discuss the strategies for both in-house manufacturing and outsourcing by presenting expert keynote presentations, live case studies and breakthrough panel discussions.
Topics to be Covered Introduction To Antibody Conjugates Overview Of Techniques In Quantitative Pharmacology No Such Thing As A Magic Bullet: The Hidden Challenges Of ADC Discovery And Development...